Biochemical premotor biomarkers for Parkinson's disease
- PMID: 22508282
- PMCID: PMC3428741
- DOI: 10.1002/mds.24956
Biochemical premotor biomarkers for Parkinson's disease
Abstract
A biomarker is a biological characteristic that is objectively measured and evaluated as an indicator of normal biological or pathologic processes or of pharmacologic responses to a therapeutic intervention. We reviewed the current status of target protein biomarkers (eg, total/oligomeric α-synuclein and DJ-1) in cerebrospinal fluid, as well as on unbiased processes that can be used to discover novel biomarkers. We have also provide details about strategies toward potential populations/models and technologies, including the need for standardized sampling techniques, to pursue the identification of new biochemical markers in the premotor stage of Parkinson's disease in the future.
Copyright © 2012 Movement Disorder Society.
References
-
- Chaudhuri KR, Naidu Y. Early Parkinson's disease and non-motor issues. J Neurol. 2008;255(Suppl 5):33–38. - PubMed
-
- Del Tredici K, Hawkes CH, Ghebremedhin E, Braak H. Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease. Acta Neuropathol. 119:703–713. - PubMed
-
- Valappil RA, et al. Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson's disease. Mov Disord. 25:2296–2303. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous